Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Tissue Engineering and Regenerative Medicine is Scopus-indexed (Q1, CiteScore 8.5), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Korean Tissue Engineering and Regenerative Medicine Society.
Checked against the index lists dated .
ISSN 1738-2696Verify ISSN ↗2212-5469Verify ISSN ↗
Publisher: Korean Tissue Engineering and Regenerative Medicine Society
Cost to publish: About US$4,090 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medicine (miscellaneous) | 51 / 466 | 89th | Q1 |
| Biomedical Engineering | 78 / 342 | 77th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2008–present, best quartile Q1, CiteScore 8.5.
Tissue Engineering and Regenerative Medicine is Q1 in Medicine (miscellaneous) (rank 51 of 466) and Q1 in Biomedical Engineering (rank 78 of 342), by CiteScore 2025.
Tissue Engineering and Regenerative Medicine is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 8.5, which places it in quartile Q1 at the 89th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.970, quartile Q1, with an H-index of 50.
The publisher lists an article processing charge of about US$4,090 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Tissue Engineering and Regenerative Medicine is published by Korean Tissue Engineering and Regenerative Medicine Society. Its print ISSN is 1738-2696 and its online ISSN is 2212-5469.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Tissue Engineering and Regenerative Medicine has an h-index of 58 and a 2-year mean of 4.21 citations per paper (OpenAlex). Its Scopus CiteScore is 8.5, quartile Q1. On 2-year citations it ranks #64 of 451 Scopus journals in Medicine (miscellaneous).
Tissue Engineering and Regenerative Medicine published 111 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2025–2026), authors are most often from South Korea (47.4%), China (23.8%) and United States (5.4%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.